The AMARA (As Much As Reasonably Achievable) Study

ConditionLiver Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital of Patras

About this trial

Subjects with large inoperable liver tumors defined as at least 1 lesion larger than 5cm in maximum diameter. For the purposes of the present study, we define the AMARA principle in intensified regional TARE as a planned irradiated tumor dose \>200Gy by the partition model. The purpose of the study is to evaluate the safety and efficacy of Y90 high dose radioembolization for the management of large inoperable liver tumors. In addition, to correlate the safety and efficacy with the post-treatment dosimetry analysis (by MIM Software Inc) based on 90Y-PET/CT imaging.

Eligibility criteria

Qualifiers

Age >18 yr

Both sexes eligible for study

Patients with primary or secondary liver tumors

Liver dominant disease

Disqualifiers

Child Pugh > B

Bilirubin >2 mg/dl

Albumin<3.0

Central portal invasion

Trial design

Treatments tested in this trial

  • Transarterial Radioembolization

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators